Jinyu Bio-Technology Co

Jinyu Bio-Technology Co P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Jinyu Bio-Technology Co (600201.SS) as of Oct 27, 2026 is 54.17. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 59.14 — a change of -8.40% (lower).

P/CF

54.17

YoY

-8.40%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Jinyu Bio-Technology Co is 2025 54.17 . P/CF (Price-to-Cash-Flow Ratio) of Jinyu Bio-Technology Co was 2024 59.14 . It decreases by -8.40% lower compared to the previous year.

The Jinyu Bio-Technology Co P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2018
40.53 CNY
Jan 1, 2019
42.25 CNY
Jan 1, 2020
24.48 CNY
Jan 1, 2021
32.12 CNY
Jan 1, 2022
49.68 CNY
Jan 1, 2023
41.28 CNY
Jan 1, 2024
59.14 CNY
Jan 1, 2025
54.17 CNY
The Jinyu Bio-Technology Co P/CF history
YEARP/CFYoY
54.17-8.40%
59.14+43.27%
41.28-16.92%
49.68+54.67%
32.12+31.24%
24.48-42.08%
42.25+4.25%
40.53+111.01%
19.21-15.18%
22.65-34.62%
34.64+18.38%
29.26—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jinyu Bio-Technology Co Stock analysis

What does Jinyu Bio-Technology Co do? Jinyu Bio-Technology Co., Ltd. generates revenue by researching, developing, producing, and selling veterinary biological products, with a primary focus on veterinary vaccines. The company operates from its headquarters in Hohhot, Neimenggu, where it employs 1,618 full-time staff members to support these core activities. In addition to its main veterinary operations, the firm diversifies its income streams by engaging in textile processing, providing energy products, and offering property leasing and management activities. These supplementary services allow the company to serve various market segments beyond the veterinary sector. The business model relies on the direct sale of its veterinary vaccines and biological products to customers in the animal health industry. By integrating manufacturing with research and development, Jinyu Bio-Technology Co., Ltd. maintains control over its product quality and supply chain while expanding into related industrial and service areas. Jinyu Bio-Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jinyu Bio-Technology Co stock

P/CF (Price-to-Cash-Flow Ratio) of Jinyu Bio-Technology Co is 54.17 in 2025.

P/CF (Price-to-Cash-Flow Ratio) of Jinyu Bio-Technology Co changed from 59.14 to 54.17, representing a -8.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Jinyu Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Jinyu Bio-Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Jinyu Bio-Technology Co

All Key Metrics — Jinyu Bio-Technology Co